In this study, we analyzed the expression and post-translational modification of Shc adapter proteins in two independent cohorts of patients with breast cancer by a semi-quantitative immunohistochemistry (IHC) staining method and found the Shc proteins to be strongly predictive for disease recurrence in tamoxifen-treated patients. This evidence concerns the gene PROS1 and breast carcinoma.